Town Hall Ventures
VC Fund
New York, United States
Town Hall Ventures is an investment firm aimed at transforming the woefully broken U.S. health care market through technology. It is dedicated to working side-by-side with visionary entrepreneurs who want to transform care delivery and health outcomes for the most underserved and higher need populations across the country.Town Hall seeks toinvest in and support the best entrepreneurs - those bold enough to want to change the system and impact millions of lives.
- Total investments:
- 67
- Last investment:
- Lead investor:
- 12%
- Fund size:
- $350M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Town Hall Ventures invests in
Stages Town Hall Ventures invests in
Countries Town Hall Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $5M–$80M
- Series B
- $15M–$100M
- Series C
- $30M–$200M
Investment Focus
Industry
- Health Care 35 (52%)
- Medical 18 (27%)
- Hospital 8 (12%)
- Wellness 4 (6%)
- Information Technology 4 (6%)
Stage
- Series B 17 (25%)
- Series C 13 (19%)
- Series A 9 (13%)
- Seed 7 (10%)
- Series D 5 (7%)
Country
- United States 35 (52%)
- Panama 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Andy Slavitt
General Partner
|
General Partner | Total investments: 7 | Find email | |
Anna Fagin
Vice President & Principal
|
Vice President & Principal | Total investments: 0 | Find email | |
Catherine Olexa-Meadors
Head of Partnerships and Growth
|
Head of Partnerships and Growth | Total investments: 0 | Find email | |
David Whelan
Co-Founder and General Partner
|
Co-Founder and General Partner | Total investments: 10 | Find email | |
Hui Cheng
Senior Associate and Investor
|
Senior Associate and Investor | Total investments: 1 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Kin Health
|
Kin transforms any medical visit into momentum, becoming the default patient AI layer that works in any exam room today: patient-controlled, privacy-forward, and built to make care feel less complex and more manageable in critical moments. | $9M / Seed / May 18, 2026 | |
Jimini Health
|
Jimini’s mission is to radically improve the efficacy of mental health care across the world. Jimini has developed a novel care model that combines teletherapy sessions with personalized AI support. With Jimini, your therapy care team includes your licensed clinician and Sage, your always-available AI therapy assistant, who work together to helpyou achieve your goals.Founded in 2023 by a team of seasoned AI and biotech entrepreneurs, health tech veterans, and psychology researchers, Jimini puts science and tech first, using safe, purpose-built patient-facing technology that works exclusively under clinical oversight and high safety standards.World leaders in psychology designed Jimini’s care model to ensure that every part of the patient's journey is clinically beneficial. Jimini does not believe that LLMs should replace clinicians; rather, AI will help therapists deliver higher-quality care and focus on the most complex parts of their job. Jimini’s care model is first and foremost led by excellent clinicians.Jimini is committed to improving mental health quality and creating radically better, more modern, and clinically efficacious mental health experiences for patients. | $17M / Seed / Mar 31, 2026 | |
Qualified Health
|
Qualified Health is a reliable partner for safely utilizing generative AI in medicine. Qualified Health's infrastructure solution offers safeguards for ongoing algorithm performance monitoring, active AI governance, and developing agents tailored to the healthcare industry. Qualified Health are revolutionizing healthcare in America with tophealth system partners. | $125M / Series B / Mar 25, 2026 | |
Indigo
|
Indigo is an insurance company that provides medical professional liability insurance to physicians and groups. Indigo uses data-driven underwriting, rapid quoting, competitive rates, and rigorous defense to offer a better insurance experience for their clients. The company was founded in 2023 and is based in Nashville, Tennessee. | $50M / Series B / Jan 29, 2026 | |
House Rx
|
House Rx is a health technology platform focused on improving affordability and patient access to specialty medications. | $55M / Series B / Nov 12, 2025 | |
Marble Health
|
Marble Health provides access to personalized therapy to help teens in their mental health journey. Marble Health provides prompt and affordable care for middle and high school students experiencing common mental health issues such as anxiety, depression, and trauma. They ensure that all teens and their families can access treatment using theirexisting insurance coverage, including both commercial and Medicaid plans. | $15.5M / Series A / Oct 14, 2025 | |
Thyme Care
|
Thyme Care is a healthcare company that provides oncology care management services. The company offers a patient- and provider-integrated oncology solution, partnering with health plans to facilitate whole-person care for their members. Thyme Care seeks to revolutionize cancer care by providing personalized and holistic support to patients. Thecompany envisions a future where every cancer patient can access high-quality, individualized care that meets their unique needs and circumstances. | $97M / Series D / Sep 25, 2025 | |
Strive Health
|
Strive Health is a built-for-purpose company working with innovative payers and providers to transform kidney care. Strive Health significantly improves patient outcomes and experience with a high-touch, technology-enabled clinical model that cares for chronic kidney disease patients across their entire healthcare journey, from primary care-levelengagement through dialysis.Strive was launched out of Oxeon’s Venture Studio and is backed by New Enterprise Associates, Town Hall Ventures, Echo Health Ventures, and Ascension Ventures. | $300M / Series D / Sep 09, 2025 | |
Ambience Healthcare
|
Ambience Healthcare develops an AI operating system used for documentation, coding, and clinical workflows in healthcare settings. The company builds an AI medical scribe that captures clinician-patient conversations in real time and converts them into clinical notes. Its scribe tool includes speech recognition, real-time documentation, and AIfeatures designed to integrate with electronic medical record systems. The tool generates notes within seconds and allows customization based on user preferences. | $243M / Series C / Jul 29, 2025 | |
Arine
|
Arine offers a comprehensive medication management platform that identifies and supports individuals at risk of medication-related problems to prevent negative health events. The platform integrates clinical expertise and data analytics to optimize medications and improve health outcomes. | $30M / Series C / May 16, 2025 | |
| See all 67 investments → | |||
Co-Investors
Echo Health Ventures
11 deals together
New Enterprise Associates
11 deals together
Bessemer Venture Partners
9 deals together
Flare Capital Partners
8 deals together
Frist Cressey Ventures
8 deals together
CVS Health Ventures
7 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Town Hall Ventures invest in?
Town Hall Ventures invests primarily in Health Care, Medical and Hospital startups, most often at Series B and Series C stage. Most of the 67 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Town Hall Ventures's check size?
Town Hall Ventures typically joins rounds of $5M–$80M at Series A, $15M–$100M at Series B and $30M–$200M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Town Hall Ventures participates in.
How do I contact Town Hall Ventures?
Public channels for Town Hall Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Town Hall Ventures?
The team at Town Hall Ventures includes Andy Slavitt (General Partner), Anna Fagin (Vice President & Principal) and Catherine Olexa-Meadors (Head of Partnerships and Growth), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
